Level-headed reportage. What's critical is regulation and health surveillance. With increased utilization of any chemical in large populations adverse events appear. Will there be a regulatory process like that emerging at FDA for tobacco?
A. Budney comments in this article
 LA Times Science (@LATimesscience)10/10/10 3:04 AM A bit of tarnish on marijuana's benign reputation http://lat.ms/aINuk9 |
Sent from my iPhone
No comments:
Post a Comment